Accordingly, developed USP14 inhibitors could be used to elucidate the role of ubiquitin-conjugation machinery in ferroptosis defense and may represent a promising therapeutic strategy for radiosensitization in HCC. This evidence concerns the gene USP14 and hepatocellular carcinoma.